Robot-assisted radical prostatectomy – A single institute experience  by Chen, Chia-Hung et al.
Abstracts / Urological Science 27 (2016) S1eS23 S9intraoperative and postoperative morbidity in literature review. Robotic
assisted radical prostatectomy (RaRP) provides a better surgical view
compared to conventional RRP. Ideally, it might provide a better vision to
navigate the difﬁcult surgical planes of previous surgeries. In this study, we
compared the peri- and post-operative outcomes of RaRP in patients un-
derwent a prior TURP.
Materials and Methods: We retrospectively enrolled 249 patients who
received RaRP from 2009 to 2016 by two experienced robotic surgeons in
our hospital. Sixteen patients accepted a prior TURP. Total 16 patients had
previous history of TURP (study group). The perioperative parameters,
pathologic characteristics, complications, and voiding function outcomes
were compared between the study group and those who didn't underwent
a prior TURP (control group).
Results: Among the 16 patients, 3 patients had benign pathology of TURP
in 5, 8 and 11 years prior to RaRP. One patient was diagnosed to have cT1a,
Gleason 1+1 prostate cancer after TURP. The other 12 patients was
diagnosed Gleason gradeS6 prostate cancer after TURP and they had a
mean time of 4 months (1.1e8.4 months) between TURP and RaRP. Mean
operative time was similar between the study and control group (245.3
vs. 249.9 minutes, p¼ 0.711), mean blood loss was similar (85.8 vs.
93.5 cc, p¼ 0.824), post operation Foley indwelling time and hospital stay
were also similar (6.7 vs. 4.3 days, p¼ 0.153; 7.0 vs. 6.2 days, p¼ 0.192).
We performed bilateral neurovascular bundle (NVB) sparing, unilateral
NVB sparing in 62.5%, 18.8% of study group patients, which was not less
than control group (bilateral NVB sparing/unilateral NVB
sparing¼ 64.8%/26.6%, p¼ 0.852). The positive surgical margin rate was
similar between study and control group (18.8% vs. 27.0%, p¼ 0.571). The
overall complication rate in study group was 31.25% (Clavien grade I: 5
patients), and 15.45% in control group (Clavien grade I: 30 patients,
Clavien grade II: 2 patients, Clavien grade IIIa: 1 patient, Clavien grade
IIIb: 3 patients). Although the complication rate in study group seemed
higher then control group, it did not reach statistical signiﬁcance
(p¼ 0.231). Regarding post-operative continence, no difference could be
observed between the 2 groups in terms of post-operative pad free rate
(62% vs 68%, p¼ 0.8412).
Conclusion: RaRP might be challenging after a prior TURP. However, the
peri- and post-operative outcomes were not compromised in experienced
hands.
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Purpose: Upper urinary tract urothelial carcinoma (UT-UC) is rare and,
according to the current guidelines, treatment options or prognostic
markers are limited. There is increasing evidence indicating that urothelial
carcinoma may be an endocrine-related cancer. The aim of this study was
to analyze data from a single tertiary referral center in Taiwan and identify
the prognostic effect of estrogen receptor beta (ERb) on the outcome of UT-
UC.
Materials and Methods: From 2005 to 2012, 188 patients with pT3 UT-UC
were treated at our institution. Only 115 patients with solitary renal pelvis
or ureteral tumor underwent radical surgery. This study included 105
patients with adequate specimen quality. Perioperative factors, patholog-
ical features, and ERb immunostaining were reviewed and prognostic ef-
fects were examined by multivariate analysis.
Results: This study divided patients into either the ERb-positive (n¼ 52)
or ERb-negative (n¼ 53) group and analyzed their oncologic outcomes. All
pathological features except inﬁltrating tumor architecture (signiﬁcantly
higher incidence in ERb-negative groups, p¼ 0.004) are symmetric in both
groups. Negative ERb expression was signiﬁcantly correlated with local
recurrence and distant metastasis in univariate analysis (p¼ 0.035 and
0.004, respectively) and multivariate analysis (p¼ 0.05 and 0.008,
respectively).
Conclusion: This study identify the role of ERb in UT-UC and this result
may help identify patients in need of adjuvant therapy or develop potential
targeted therapy.PD5-5:
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Purpose: The aim of this study was to describe surgical, oncological and
functional outcomes for patients undergoing robot-assisted radical pros-
tatectomy (RARP)
Materials and Methods: From 2009 to November 2015, total 362 patients
with prostate cancer were treated with robot-assisted radical prostatec-
tomy at Taipei Veterans General Hospital. We collected patient and tumor
characteristics. Perioperative outcomes, oncologic outcome, and func-
tional outcomes were recorded.
Results: Total 362 patients were included in our study. The mean age was
63.35± 5.23 and the mean body mass index was 25.0± 2.36. Mean pre-
operation PSA was 11.7± 6.37. Mean estimated blood loss was
190.7± 191.92ml. Mean days of Foley removal was 5.6± 2.63. Mean days of
post-op hospital days was 6.65± 1.85. Complications occurred in 75 cases
(20%), with 58 gradeI, 12 gradeII, 2 gradeIIIa, and 3 gradeIIIb by Clavien-
Dindo classiﬁcaiton. Positive surgical marginwas 28%. Continence rate was
85.56% % after 1 year follow-up. Potency rate was 60.81% after 1 year
follow-up. Biochemical recurrence ratewas 13.56%. Mean follow-up period
was 28.24± 17.89 months. Factor will inﬂuence biochemical recurrence
including value of PSA, gleason score, risk group, and margin status.
Conclusion: According to our study and literature review. RARP is a safe
procedure with regard to perioperative results. Functional outcome was
better than previous study in our hospital.
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Purpose: Pelvic lymph node dissection has been known as the standard
procedure in patient with muscle invasive bladder cancer during radical
cystectomy. Our purpose is to map the sentinel lymph node by intra-
operatively injecting indocyanine green (ICG) which can be detected by
near-infrared (NIR).
Materials and Methods: This study included 10 patients with muscle
invasive bladder cancer. ICG solution was administrated serosally around
the tumor. NIR was used to detect the ICG intake area. Extended pelvic
lymph node dissection was performed.
Results: Intra-operative ICG injection peritumorally could achieve well
identiﬁcation of sentinel lymph node not only in-vivo but also ex-vivo.
Extended lymph node dissection during operation was performed. In
comparewith pathology report, perioperative ﬂuorescence couldmakewell
mapping of lymph node. There was no complication during ICG injection.
Conclusion: Using intraoperative ICG injection can safely and successfully
achieve sentinel lymph node mapping. However, further clinical study
with large patient number may be needed.
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